Stocks · Healthcare · Medical - Devices
Orthofix Medical Inc. OFIX
$9.09 -1.30% Close, Oct 2, 2026 · NASDAQ · Market cap $367.4M
Weak trend
Next earnings report: Nov 3, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Operating margin widened to -3.1% from -11.8% a year earlier.
- The stock is in a downtrend: below its 200-day average, with the 50-day average below the 200-day.
- Over the past year the stock returned -36.6%, behind the S&P 500 by 51.7 percentage points.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 35%
- FCF growth (TTM, YoY)Bottom 1%
- Revenue growth, 3-year CAGRTop 29%
- Revenue growth accelerationTop 40%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 36%
- Gross marginTop 43%
- Operating marginTop 45%
- Accruals (lower is better)Top 38%
- Net debt / EBITDA (lower is better)Top 50%
- Interest coverTop 48%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldBottom 37%
- Free-cash-flow yieldBottom 43%
- EBITDA / enterprise valueTop 3%
- Sales / enterprise valueTop 6%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 13%
- 6-month returnBottom 23%
- 1-year return vs S&P 500Bottom 18%
- Distance from 52-week highBottom 32%
- Trend checklist (0–4)Bottom 14%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 5%
- Consecutive EPS beatsTop 25%
- Share of analysts rating BuyBottom 14%
- Upside to consensus price targetBottom 43%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 43%
- Maximum drawdown, 3 yearsTop 31%
- Beta vs S&P 500 (lower is better)Top 43%
- Net debt / EBITDA (lower is better)Top 50%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 2.6% | 3.0% | ↑ |
| Gross margin | 67.4% | 69.6% | ↑ |
| Operating margin | -11.8% | -3.1% | ↑ |
| FCF margin | 0.1% | -3.2% | ↓ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 3.0% | 2.6% | ↑ | Bottom 35% |
| Gross margin | 69.6% | 67.4% | ↑ | Top 43% |
| Operating margin | -3.1% | -11.8% | ↑ | Top 45% |
| Net margin | -7.4% | -15.3% | ↑ | — |
| Free-cash-flow margin | -3.2% | 0.1% | ↓ | — |
| Return on invested capital | -3.5% | — | Top 36% | |
| Revenue growth, 3-year CAGR | 21.3% | — | Top 29% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -9.0%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 5.1%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- +1.8 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- 1.22×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- -1.2×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -1.51%
- Shareholder yield
- -1.51%
- Share count change, 1 year
- +3.6%
- Share count change, 3-year CAGR
- +3.6%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 5, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 3
- Beats in the last 8 reports
- 5 of 8
- Average EPS surprise, last 4
- -100.0%
- Average 2-day reaction, last 8
- -3.3%
- Positive 20 days after report
- 2 of 8
Analysts
- Consensus price target
- $13.40
- Target vs current price
- +47.4%
- Analysts with a rating
- 17
- Share rating Buy or Strong Buy
- 47%
- Consensus rating
- Hold
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 5, 2026 | +4.9% | -14.6% | -15.4% | -22.7% | — |
| May 5, 2026 | +23.5% | +3.6% | -2.8% | -19.2% | -1.8% |
| Feb 24, 2026 | +70.8% | -6.2% | -1.6% | -12.7% | -11.0% |
| Nov 4, 2025 | -575.0% | -7.4% | -6.4% | -2.1% | -17.6% |
| Aug 5, 2025 | +18.2% | +13.5% | +19.3% | +37.2% | +47.6% |
| May 6, 2025 | -255.3% | -10.9% | -8.2% | -18.5% | -18.5% |
| Feb 25, 2025 | -2600.0% | -3.5% | -6.4% | -7.8% | -33.9% |
| Nov 7, 2024 | +146.7% | -1.0% | +1.3% | +0.9% | +3.5% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 5, 2026 | -$0.39 | -$0.41 | +4.9% | $210.9M |
| May 5, 2026 | -$0.52 | -$0.68 | +23.5% | $196.7M |
| Feb 24, 2026 | -$0.06 | -$0.19 | +70.8% | $219.9M |
| Nov 4, 2025 | -$0.57 | $0.12 | -575.0% | $205.6M |
| Aug 5, 2025 | -$0.36 | -$0.44 | +18.2% | $200.7M |
| May 6, 2025 | -$1.35 | -$0.38 | -255.3% | $193.6M |
| Feb 25, 2025 | -$0.75 | $0.03 | -2600.0% | $215.7M |
| Nov 7, 2024 | $0.07 | -$0.15 | +146.7% | $196.6M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| EV / EBITDA | 4.7× | — | — | Top 3% |
| EV / Sales | 0.60× | — | — | Top 6% |
| Free-cash-flow yield | -7.36% | — | — | Bottom 43% |
| Earnings yield | -16.89% | — | — | Bottom 37% |
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✗ Price above 200-day average
- ✗ 50-day average above 200-day
- ✓ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- -6.6%
- 200-day average slope (20 days)
- -5.2%
- Distance from 50-day average
- -8.7%
- Distance from 200-day average
- -22.2%
- RSI (14)
- 43.7
- Relative volume
- 0.78×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 51.7%
- Volatility vs own 5-year history
- 75th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.98
- Correlation with S&P 500
- 0.36
- Current drawdown from 1-year high
- -44.0%
- Maximum drawdown, 3 years
- -56.8%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Feb 24, 2021 | Sep 17, 2026 | -82.0% | 1397 days | Not yet recovered |
| Jan 12, 2021 | Jan 29, 2021 | -10.2% | 12 days | 15 days (Feb 22, 2021) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $367.4M
- EPS, diluted (TTM)
- -$1.54
- Revenue (TTM)
- $833.2M
- 52-week range
- $8.50 – $16.99
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $464.5M | $460.7M | $746.6M | $799.5M | $822.3M |
| Gross profit | $349.6M | $337.2M | $486.3M | $545.9M | $551.7M |
| Operating income | -$8.3M | -$13.3M | -$139.1M | -$84.6M | -$68.5M |
| Net income | -$38.4M | -$19.7M | -$151.4M | -$126.0M | -$92.2M |
| EPS (diluted) | -$1.95 | -$0.98 | -$4.12 | -$3.30 | -$2.28 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $196.6M | $215.7M | $193.6M | $203.1M | $205.6M | $219.9M | $196.7M | $210.9M |
| Net income | -$27.4M | -$29.1M | -$53.1M | -$14.1M | -$22.8M | -$2.2M | -$20.9M | -$15.8M |
| EPS (diluted) | -$0.71 | -$0.75 | -$1.35 | -$0.36 | -$0.57 | -$0.06 | -$0.52 | -$0.39 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $18.5M | -$11.5M | -$45.8M | $25.8M | $33.3M |
| Capital expenditure | -$19.6M | -$23.2M | -$62.0M | -$34.9M | -$34.6M |
| Free cash flow | -$1.1M | -$34.7M | -$107.8M | -$9.1M | -$1.3M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $8.8M | $4.3M | $5.1M | $6.3M | $5.9M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $103.8M
- Total assets
- $873.0M
- Total liabilities
- $443.8M
- Total debt
- $234.6M
- Net debt
- $130.8M
- Shareholders’ equity
- $429.2M
As of Jun 30, 2026 (filed Aug 5, 2026).
Short interest
- Shares sold short
- 2,506,524
- Days to cover
- 7.10
- Change vs previous report
- +5.5%
FINRA short interest, settlement date Sep 15, 2026.